Covance establishes new global unit for biologic drug development

This article was originally published here

LabCorp’s Covance Drug Development business has established a global immunology and immunotoxicology (I&I) unit to focus on the development of biologic drugs.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply